the risk of jaw bone damage while taking Fosamax or other bisphosphonates
August 2006
Lots of worried patients are asking about the risk of jaw bone damage while taking Fosamax or other bisphosphonates.
Questions about osteonecrosis of the jaw have really picked up since we alerted you to this rare problem last year.
The incidence is very low for patients taking ORAL Fosamax, Actonel, or Boniva for osteoporosis. It's probably less than 1 case per 100,000 patients per year.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote